Medicover Cancer Institute, Arilova, Visakhapatnam

Medicover Cancer Institute in Arilova, Visakhapatnam, is a dedicated oncology facility within the Medicover Hospitals network, distinct from Medicover's other Visakhapatnam multispecialty hospitals. It treats major cancer types, including breast, lung, liver, colon, prostate, cervical, oral and blood cancers.

Services bring together medical, surgical and radiation oncology under one roof, with chemotherapy day-care and targeted therapy delivered by a team of oncologists, cancer surgeons and radiation therapy specialists. The institute offers bone marrow transplantation for leukaemia, lymphoma and other blood disorders, with the procedure managed by its haemato-oncology team.

For diagnosis and staging, the institute states it was the first in Visakhapatnam to introduce a 4D PET-CT scanner, used to assess how far a cancer has spread and to plan treatment accordingly, alongside conventional imaging and pathology services.

The institute's page lists oncology sub-services including haemato-oncology, surgical oncology, uro-oncology, breast oncology, thoracic oncology, oncoplastic surgery, colorectal surgery and nuclear medicine. Medical oncology uses chemotherapy, hormone therapy, targeted therapy and immunotherapy, and the page also mentions paediatric cancer care. Surgical oncology is described for head and neck, breast, gynaecological and gastrointestinal cancers, with minimally invasive operations and reconstructive, organ-preserving procedures.

Key facilities named on the page are MRI, CT, ultrasound and digital X-ray alongside a full-fledged nuclear medicine department and specialised isolation units. The bone marrow transplant service is described as including protected isolation units, an infection-controlled treatment environment, pre-transplant evaluation and post-transplant monitoring. Supportive services listed include pain and palliative care, physiotherapy and rehabilitation, and nutritional and psychological support.

International patients may consider this centre when the treatment needed is primarily oncological rather than general multispecialty care. Confirm the exact cancer type, proposed treatment and named oncologist directly with the hospital before travelling.